![]()
|
|
||||||||
J Biol Chem, Vol. 273, Issue 36, 22913-22920, September 4, 1998
- and
-Chains of Hepatocyte
Growth Factor on c-Met Receptor Confers Ligand-induced Receptor
Tyrosine Phosphorylation and Multiple Biological Responses
From the Division of Biochemistry, Biomedical Research Center,
Osaka University Medical School, Suita, Osaka 565-0871, Japan
Hepatocyte growth factor (HGF) is a heterodimeric
molecule composed of the
-chain containing the N-terminal hairpin
domain, four kringle domains, and the serine protease-like
-chain.
We prepared HGF/NK4 and HGF/
from the entire HGF after single-cut digestion with elastase. HGF/NK4 contains the N-terminal hairpin and
four kringle domains, while HGF/
is composed of the C-terminal 16 amino acids of the
-chain and the entire
-chain, linked by a
disulfide bridge. HGF/NK4 competitively inhibited the binding of
125I-HGF to the receptor, and affinity cross-linking
analysis indicated that HGF/NK4 alone can bind to the c-Met receptor.
In contrast, HGF/
alone did not competitively inhibit the binding of
125I-HGF to the receptor and did not bind to the c-Met/HGF
receptor. Scatchard analysis and affinity cross-linking experiments
indicated that HGF/
specifically binds to c-Met in the presence of
HGF/NK4 but not HGF/NK2. Neither HGF/NK4 nor HGF/
alone induced
mitogenic, motogenic (cell scattering), and morphogenic (induction of
branching tubulogenesis) responses; however, HGF/
did induce these
biological responses in the presence of HGF/NK4. Consistent with these
results, although neither HGF/NK4 alone nor HGF/
alone induced
tyrosine phosphorylation of the c-Met/HGF receptor, HGF/
induced
tyrosine phosphorylation of the receptor when c-Met/HGF receptor was
occupied by HGF/NK4. These results indicate that HGF/
binds to the
c-Met/HGF receptor that is occupied by HGF/NK4 and induces receptor
tyrosine phosphorylation and the subsequent biological activities of
HGF. We propose that there exists a unique cooperative interaction between
- and
-chains, this interaction leading to
-chain-dependent receptor tyrosine phosphorylation and
subsequent biological responses.
This article has been cited by other articles:
![]() |
W. W. Raymond, A. C. Cruz, and G. H. Caughey Mast Cell and Neutrophil Peptidases Attack an Inactivation Segment in Hepatocyte Growth Factor to Generate NK4-like Antagonists J. Biol. Chem., January 20, 2006; 281(3): 1489 - 1494. [Abstract] [Full Text] [PDF] |
||||
![]() |
D. Kirchhofer, X. Yao, M. Peek, C. Eigenbrot, M. T. Lipari, K. L. Billeci, H. R. Maun, P. Moran, L. Santell, C. Wiesmann, et al. Structural and Functional Basis of the Serine Protease-like Hepatocyte Growth Factor {beta}-Chain in Met Binding and Signaling J. Biol. Chem., September 17, 2004; 279(38): 39915 - 39924. [Abstract] [Full Text] [PDF] |
||||
![]() |
T. A. Martin, C. Parr, G. Davies, G. Watkins, J. Lane, K. Matsumoto, T. Nakamura, R. E. Mansel, and W. G. Jiang Growth and angiogenesis of human breast cancer in a nude mouse tumour model is reduced by NK4, a HGF/SF antagonist Carcinogenesis, August 1, 2003; 24(8): 1317 - 1323. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. Saimura, E. Nagai, K. Mizumoto, N. Maehara, Y. A. Minamishima, M. Katano, K. Matsumoto, T. Nakamura, and M. Tanaka Tumor Suppression through Angiogenesis Inhibition by SUIT-2 Pancreatic Cancer Cells Genetically Engineered to Secrete NK4 Clin. Cancer Res., October 1, 2002; 8(10): 3243 - 3249. [Abstract] [Full Text] [PDF] |
||||
![]() |
F. LIU, K. L. SCHAPHORST, A. D. VERIN, K. JACOBS, A. BIRUKOVA, R. M. DAY, N. BOGATCHEVA, D. P. BOTTARO, and J. G. N. GARCIA Hepatocyte growth factor enhances endothelial cell barrier function and cortical cytoskeletal rearrangement: potential role of glycogen synthase kinase-3{beta} FASEB J, July 1, 2002; 16(9): 950 - 962. [Abstract] [Full Text] [PDF] |
||||
![]() |
W. G. Jiang, D. Grimshaw, J. Lane, T. A. Martin, R. Abounder, J. Laterra, and R. E. Mansel A Hammerhead Ribozyme Suppresses Expression of Hepatocyte Growth Factor/Scatter Factor Receptor c-MET and Reduces Migration and Invasiveness of Breast Cancer Cells Clin. Cancer Res., August 1, 2001; 7(8): 2555 - 2562. [Abstract] [Full Text] [PDF] |
||||
![]() |
B. Cao, Y. Su, M. Oskarsson, P. Zhao, E. J. Kort, R. J. Fisher, L.-M. Wang, and G. F. Vande Woude Neutralizing monoclonal antibodies to hepatocyte growth factor/scatter factor (HGF/SF) display antitumor activity in animal models PNAS, June 19, 2001; 98(13): 7443 - 7448. [Abstract] [Full Text] [PDF] |
||||
![]() |
W. G. Jiang, S. E. Hiscox, C. Parr, T. A. Martin, K. Matsumoto, T. Nakamura, and R. E. Mansel Antagonistic Effect of NK4, a Novel Hepatocyte Growth Factor Variant, on in Vitro Angiogenesis of Human Vascular Endothelial Cells Clin. Cancer Res., November 1, 1999; 5(11): 3695 - 3703. [Abstract] [Full Text] [PDF] |
||||
![]() |
J. Deakin and M Lyon Differential regulation of hepatocyte growth factor/scatter factor by cell surface proteoglycans and free glycosaminoglycan chains J. Cell Sci., January 6, 1999; 112(12): 1999 - 2009. [Abstract] [PDF] |
||||
![]() |
M. Lyon, J. A. Deakin, and J. T. Gallagher The Mode of Action of Heparan and Dermatan Sulfates in the Regulation of Hepatocyte Growth Factor/Scatter Factor J. Biol. Chem., January 4, 2002; 277(2): 1040 - 1046. [Abstract] [Full Text] [PDF] |
||||
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
| All ASBMB Journals | Molecular and Cellular Proteomics |
| Journal of Lipid Research | ASBMB Today |